Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 692 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sham Treatment Location Clear all

Conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Psoriasis
Interventions: Pre-filled Auto-injector Containing Placebo; Device
Lead sponsor: Centocor, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Miami, Florida • Duncansville, Pennsylvania

Conditions: Juvenile Idiopathic Arthritis (JIA)
Interventions: Active tcVNS, Sham tcVNS; Device
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 5 Years to 18 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 7
States / cities: San Francisco, California • Orlando, Florida • Indianapolis, Indiana + 4 more

Conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury
Interventions: Cool B70 AP Coil - Active (dl-PFC), Cool B70 AP Coil- Sham (dl-PFC), Cool D-B80 AP Coil - Active (dm-PFC), Cool D-B80 AP Coil - Sham (dm-PFC), Cool B70 Treatment Coil - Active Only; Device
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Pain
Interventions: Lidocaine, Placebo; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Atopic Dermatitis
Interventions: LEO 138559, Placebo; Drug
Lead sponsor: LEO Pharma; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 12
States / cities: Fountain Valley, California • Los Angeles, California • San Francisco, California + 9 more

Conditions: Phenylketonuria
Interventions: JNT-517 Suspension, Placebo Suspension, JNT-517 Tablet, Placebo Tablet; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 163 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 11
States / cities: Gainesville, Florida • Tampa, Florida • Atlanta, Georgia + 8 more

Conditions: Posttraumatic Stress Disorder
Interventions: Therapy, midomafetamine HCl, Placebo; Behavioral · Drug
Lead sponsor: Resilient Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 11
States / cities: North Hollywood, California • San Francisco, California • Boulder, Colorado + 6 more

Conditions: Parkinson's
Interventions: rTMS, Sham TMS; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 45 Years to 90 Years
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Head Lice
Interventions: Generic Ivermectin Lotion 0.5%, Sklice® (Ivermectin) Lotion 0.5%, Vehicle Lotion; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 6 Months and older
Enrollment: 905 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Hair Thinning
Interventions: Viviscal Oral Supplement Tablets; Dietary Supplement
Lead sponsor: Irish Response t/a Lifes2good; Industry
Eligibility: 24 Years to 55 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Thrombosis
Interventions: ARC1779; Drug
Lead sponsor: Archemix Corp.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Anorexia Nervosa
Interventions: quetiapine; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Healthy Volunteers
Interventions: PBI-100 Topical Cream, Positive Control - Sodium laurel sulfate (SLS), PBI-100 Topical Cream, Vehicle, Negative Control; Drug · Other
Lead sponsor: Pyramid Biosciences; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Newtown Square, Pennsylvania

Conditions: Psoriasis Vulgaris, Psoriasis
Interventions: tofacitinib ointment 20 mg/g, tofacitinib ointment 10 mg/g, placebo ointment (vehicle); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 476 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 29
States / cities: Hot Springs, Arkansas • Bakersfield, California • Irvine, California + 22 more

Conditions: Brain Concussion, Brain Trauma, Attention Concentration Difficulty, Brain Injuries, Brain Injuries, Traumatic, Neurocognitive Dysfunction, Attention Impaired, Memory Impairment, Mild Traumatic Brain Injury, Mild Cognitive Impairment
Interventions: active tDCS and cognitive training intervention, sham tDCS and cognitive training intervention; Combination Product
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Knee Osteoarthritis
Interventions: Synvisc-One Injection, Sham Injection; Device · Other
Lead sponsor: Elaine Husni; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Attention-Deficit/Hyperactivity Disorder
Interventions: Neurofeedback treatment; Device
Lead sponsor: Ohio State University; Other
Eligibility: 7 Years to 10 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 2
States / cities: Asheville, North Carolina • Columbus, Ohio

Conditions: Edema, Ecchymosis
Interventions: Hyperbaric oxygen treatment, Air sham; Drug
Lead sponsor: Restorix Research Institute, LLLP; Other
Eligibility: 40 Years to 85 Years
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Issaquah, Washington

Conditions: Postoperative Pain, Hip Arthroscopy
Interventions: Preop PENG block, Placebo block, Ropivacaine 0.5% Injectable Solution, Normal Saline; Procedure · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS)
Interventions: Zenflow Spring System, Sham Procedure; Device
Lead sponsor: Zenflow, Inc.; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 7
States / cities: Los Angeles, California • Glenview, Illinois • Las Vegas, Nevada + 3 more

Conditions: Chronic Migraine
Interventions: onabotulinumtoxinA, Topiramate, Placebo; Drug
Lead sponsor: Cady, Roger, M.D.; Individual
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Hepatocellular Carcinoma
Interventions: TheraBionic Device, Placebo Device, Quality of Life Assessment; Device
Lead sponsor: THERABIONIC INC.; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 7
States / cities: Tampa, Florida • Chicago, Illinois • Winston-Salem, North Carolina + 4 more

Conditions: Musculoskeletal Pain
Interventions: Duloxetine 30 milligrams (MG), Duloxetine 60 milligrams (MG), Placebo Oral Tablet; Drug
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Asthma
Interventions: Weight loss intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Tucson, Arizona • Burlington, Vermont

Search by objective public record fields.

A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector

Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA

Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation

Lidocaine For Treatment of Post-operative Pain From Donor Sites Following Burn Injury.

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Cognitive Dysfunction In Parkinson's

Clinical Endpoint Study of Ivermectin 0.5% Lotion

To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair

Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers

A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants

Tofacitinib Ointment For Chronic Plaque Psoriasis

tDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study

Optimization of Synvisc-One for Knee OA

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD

Effects of Hyperbaric Oxygen Therapy on Surgical Wound Healing

PENG Block for Arthroscopic Hip Surgery

Safety and Effectiveness Study of the Zenflow Spring System

A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency

Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)

Pilot of Lifestyle and Asthma Intervention